Claudin-low breast cancers share features with triple negative breast cancer (TNBC), including low levels of the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) [26]. This evidence concerns the gene ERBB2 and breast carcinoma.